Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$636,727
-$596,504 QoQ
Shares Held
4,244
-68.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#353
of 593 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $63,888,573 across 17 Diagnostics & Research names. GH ranks #15 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
33,528 | $17,650,480 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
15,605 | $8,264,251 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
12,948 | $6,491,609 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
26,210 | $5,064,296 | |
| 5 | DHR |
Danaher Corp /De/
|
25,684 | $4,892,288 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
3,146 | $4,019,046 | |
| 7 | VCYT |
Veracyte, Inc.
|
58,289 | $3,423,312 | |
| 8 | A |
Agilent Technologies, Inc.
|
22,889 | $3,040,345 |
All Filings in GH
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $636,727 | 4,244 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,233,231 | 13,351 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,889,642 | 28,291 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $250,544 | 4,010 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $201,394 | 3,870 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $215,982 | 5,070 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $383,219 | 12,544 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $416,131 | 18,140 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $583,404 | 20,201 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,224,244 | 107,816 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $949,914 | 35,117 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,097,391 | 37,024 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,265,494 | 35,349 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $830,596 | 35,435 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,496,451 | 128,546 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,583,893 | 159,463 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,554,362 | 162,478 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $9,475,035 | 143,041 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $10,517,403 | 105,153 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $12,995,789 | 103,958 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,506,904 | 108,760 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $10,173,511 | 66,646 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,264,578 | 56,367 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,668,300 | 23,871 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||